Molecular Imaging Current Events

Molecular Imaging Current Events, Molecular Imaging News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Cardiac imaging in 2020
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection, establishment of novel therapies, and selection of patients for treatment based on their individual disease biology. (2008-08-31)

SNM sharpens focus on molecular imaging innovation and translation
SNM's Molecular Imaging Center of Excellence is changing its name effective Oct. 1, 2010, to the Center for Molecular Imaging Innovation and Translation, a designation that reflects its new mission and vision. (2010-10-01)

Salt Lake City proclaims 'Molecular Imaging Days' during SNM's Annual Meeting in June
Ralph Becker, mayor of Salt Lake City, Utah, has issued an official proclamation declaring June 5-9 (2010-05-20)

SNM Symposium on Multimodality Cardiovascular Molecular Imaging
This two-day symposium focuses on advances in stem cell therapy, leading-edge research in imaging technology and targeted imaging of the cardiovascular system, including imaging of cardiovascular receptors, vascular biology, myocardial metabolism and myocardial repair. (2009-03-18)

Advances in Optics for Biotechnology, Medicine and Surgery
The primary goal of this conference is to bring together scientists, engineers and clinicians interested in the application of optics to biotechnology, medicine and surgery. Besides formal presentations, it will provide a forum for informal discussions and social interaction. In this tenth conference in this series, we aim to emphasize the medical applications of optics, with a focus on in vivo and molecular imaging, and to encourage interaction between researchers and clinicians. (2007-01-23)

Molecular imaging: diagnosing diseases before symptoms strike
Researchers at Washington University School of Medicine in St. Louis are developing methods to track molecular events in the body to diagnose disease long before symptoms appear and to predict the effectiveness of drug therapies. (2002-10-29)

Journal of Nuclear Medicine premiers new, full-color design
Beginning with the January 2009 issue, the Journal of Nuclear Medicine -- SNM's flagship publication -- will be printed in full color. (2008-12-16)

Media advisory: SNM's 57th Annual Meeting
Registration to the world's largest molecular imaging and nuclear medicine meeting now open -- and free -- for members of the media. (2010-03-05)

From the renowned Cold Spring Harbor Laboratory course
'Molecular Neuroscience: A Laboratory Manual' includes protocols used in the Advanced Techniques in Molecular Neuroscience course offered annually at Cold Spring Harbor Laboratory, as well as protocols drawn from its best-selling lab manuals. It is an essential resource for all neuroscientists, from graduate students upward, who seek to use molecular techniques to probe the complexities of the nervous system. (2014-09-25)

SNM heads to Toronto for 56th Annual Meeting
SNM recently received a warm greeting as it prepares to head north to Canada for its 56th Annual Meeting for nuclear medicine and molecular imaging. (2009-03-04)

SMASH imaging increases effectiveness of MRI for musculoskeletal imaging
Using simultaneous acquisition of spatial harmonics (SMASH) T2-weighted imaging for knee MRI results in a significant decrease in imaging time, as compared to conventional fat-saturated T2-weighted imaging, without any negative effects on MRI interpretation or patient clinical outcome, says a new study by researchers from the Neuroskeletal Imaging Institute in Melbourne, FL. (2004-05-03)

SNM applauds FDA advisory committee recommendation for approval of Alzheimer's imaging agent
The Society of Nuclear Medicine commends the US Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir. The agent, which is used in conjunction with positron emission tomography scans to detect beta amyloid plaques of the brain which may cause Alzheimer's disease, is produced by Eli Lilly and Company under the name Amyvid. (2011-01-24)

SNM applauds FDA's decision to approve Zevalin
SNM applauds the US Food and Drug Administration's recent decision to approve the radioimmunotherapy drug, Zevalin, as a front-line treatment of non-Hodgkin's lymphoma. (2009-09-10)

SNM presents awards on Capitol Hill
SNM, the world's largest society for molecular imaging and nuclear medicine professionals, honored seven legislators with special recognition awards for their outstanding support of the profession. SNM is holding its 54th Annual Meeting June 2-6 at the Washington Convention Center. (2007-06-06)

SNM receives grant from AHRQ for comparative effectiveness research
SNM has been awarded a $48,000 grant from the Agency for Healthcare Research and Quality to hold a conference to develop research on the comparative effectiveness of positron emission tomography and other molecular imaging techniques. The primary emphasis will be on the diagnosis and management of cancer patients, but both cardiology and neurology questions will also be addressed. (2010-04-13)

SNM's clinical trials network gains added support from industry leader
The SNM Clinical Trials Network, an initiative designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multicenter clinical trials, recently added Genentech Inc. as a supporter. (2009-05-14)

SNM releases new fact sheet on breast cancer and molecular imaging
Coinciding with the observance of Nuclear Medicine Week (Oct. 5 to 11) and National Breast Cancer Awareness Month (October), SNM released today a new fact sheet highlighting recent developments in molecular imaging technologies that are dramatically improving the ways in which breast cancer is diagnosed and treated. (2008-10-03)

SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
SNM's 55th Annual Meeting, (2008-05-27)

SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
SNM's 55th Annual Meeting, (2008-05-27)

New imaging method lets scientists 'see' cell molecules more clearly
Niels de Jonge, Ph.D., and colleagues at Vanderbilt University and Oak Ridge National Laboratory, have developed a unique new imaging tool. In the online early edition of the Proceedings of the National Academy of Sciences, they describe a technique for imaging whole cells in liquid with a scanning transmission electron microscope. (2009-01-19)

SNM awards $300,000 to support molecular imaging research
SNM -- an international scientific and professional organization of more than 16,000 members dedicated to promoting the practical applications, technology and science of molecular imaging and nuclear medicine -- has awarded $300,000 in research grants to support molecular imaging research. The grants, supported by SNM's Education and Research Foundation, represent the society's commitment to advancing molecular imaging and therapy by supporting the next generation of researchers. (2008-07-14)

SNM's Mid-Winter Educational Symposium for nuclear medicine and molecular imaging professionals
SNM will hold its annual Mid-Winter Educational Symposium Feb. 5-8, 2009 at the Hilton Clearwater in Clearwater, Fla. This year SNM, the American College of Nuclear Physicians and the American College of Nuclear Medicine unite to create a fused meeting, offering attendees the opportunity to earn up to 31.25 credits. (2008-12-16)

Pitt researchers' new material allows for unprecedented imaging deeper in tissues
A team from the Department of Chemistry has established an approach for the creation of a metal-organic framework material that provides new perspectives for biological imaging. (2020-06-09)

Oatmeal-labeling ideal for molecular imaging of stomach emptying
Patients undergoing molecular imaging to evaluate their stomach's ability to clear food are going to have an altogether new kind of breakfast. (2011-06-06)

Breaking down barriers in brain imaging
SNM's Molecular Imaging Center of Excellence wrapped up its Molecular Neuroimaging Symposium today in Bethesda, Md., at the Natcher Auditorium of the National Institutes of Health. (2010-05-07)

SNM to showcase the latest research in molecular imaging and nuclear medicine
SNM invites scientific investigators to submit abstracts to present their research at the society's 56th Annual Meeting -- the world's largest event dedicated to molecular imaging and nuclear medicine -- June 13-17, 2009, in Toronto, Canada. (2008-11-03)

New publication focuses on molecular imaging and cardiovascular conditions
The Journal of Nuclear Medicine -- the top-rated medical imaging journal worldwide -- has published Multimodality Molecular Imaging of the Cardiovascular System, presenting the state of the art of cardiovascular molecular imaging and discussing opportunities and challenges in advancing cardiovascular molecular imaging to clinical practice. (2010-05-03)

Pioneering new technique could revolutionise super-resolution imaging systems
Scientists have developed a pioneering new technique that could revolutionise the accuracy, precision and clarity of super-resolution imaging systems. (2021-01-21)

SNMMI publishes appropriate use criteria for somatostatin receptor PET imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors. This AUC is part of a new series developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for Advanced Diagnostic Imaging. The AUC for somatostatin receptor PET imaging addresses several clinical scenarios for diagnosing neuroendocrine tumors (NETs). (2018-01-04)

SNM seeks novel approaches to molecular imaging to showcase at annual meeting
Attention scientific researchers: SNM invites you to present your molecular imaging studies -- especially those involving nonradioactive molecular imaging techniques and agents -- at the society's 55th Annual Meeting June 14-18, 2008, in New Orleans, La. SNM, the world's largest society for molecular imaging and nuclear medicine professionals, will showcase these studies in a new scientific investigation track called (2007-09-20)

SNM experts focus on advances in molecular imaging for cancer, addiction, Alzheimer's, heart disease
Leading medical investigators will present recent developments in the diagnosis of cancer and heart and brain diseases during the Society of Nuclear Medicine's Mid-Winter Educational Symposium Feb. 11-12 at Wyndham Buttes in Tempe, Ariz. (2006-01-30)

Better imaging from bench to bedside
Euro-BioImaging, a project which launches its preparatory phase today, aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research, from bench to bedside. (2010-12-02)

SPECT provides high-quality images of small tumors
A new study shows that combining high resolution and high sensitivity collimation provides better quality images when using single photon emission computed tomography (SPECT) scans, said researchers at SNM's 56th Annual Meeting. (2009-06-15)

SNM and ASTRO team up to advance molecular imaging and cancer research
SNM and the American Society for Therapeutic Radiation and Oncology will cosponsor a symposium this fall examining the impact of translational advances on radiation oncology and cancer imaging. The two-day meeting, which takes place Oct. 17-18, will bring together some of the world's leading experts and young investigators in the emerging field of molecular imaging. (2008-08-22)

SNM urges Congress to support CARE bill
SNM is calling on Congress to support the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act (CARE) bill, which would ensure that states set minimum education and credentialing standards for nuclear medicine technologists. The bill was introduced Sept. 28 in the US House of Representatives by Rep. John Barrow (D-Ga.). (2009-09-29)

Molecular imaging 'probes' pinpoint prostate cancer
Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research introduced at SNM's 57th Annual Meeting demonstrates how a novel peptide-targeted imaging agent could help clinicians detect a biological process that signals cancer in prostate cells. Information gathered about this process may even differentiate prostate tumor types and the progression of disease. (2010-06-07)

SNM applauds US Senate's introduction of CARE Act
SNM supports the US Senate in its introduction of the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2010 (CARE Act), S. 3737. The proposed legislation, which was introduced in August by Sen. Mike Enzi (R-Wyo.), aims to ensure that minimum education and credentialing standards for nuclear medicine technologists are set at the state level. (2010-08-25)

New chemistry techniques improve hybrid scanner performance
A new PET/MR imaging system has been developed that can successfully provide whole-body images of rats and other small animals, according to researchers at SNM's 56th Annual Meeting. (2009-06-15)

Feet first: Molecular imaging helps diagnose diabetic foot infection
A study presented at SNM's 57th Annual Meeting shows that using multiple imaging agents with a hybrid imaging technique can be a valuable tool for accurately diagnosing and determining treatment for a variety of diabetes-associated foot diseases. (2010-06-07)

Molecular imaging finds novel way to knock down breast cancer
For years researchers have been developing molecular imaging techniques that visualize hormonally active breast cancer cells -- specifically those testing positive for human epidermal growth factor receptor 2. A recent innovation in breast cancer biomarkers seeks the HER3 receptor instead, which could mean more comprehensive breast cancer imaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. (2014-06-09)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to